Redmile Group »

D Fluidigm Corp Del shares owned by Redmile Group

Quarter-by-quarter ownership of D Fluidigm Corp Del (LAB) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in D Fluidigm Corp Del

Tip: Access up to 7 years of quarterly data

All positions including D Fluidigm Corp Del held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in D Fluidigm Corp Del by Redmile Group

Quarter filed Position value Share count Share price at filing
2012-09-30 $2.6M 154k 17.00

More positions owned by Redmile Group

Krystal Biotech (KRYS)
Amicus Therapeutics (FOLD)
Immunome (IMNM)
Scholar Rock Hldg Corp (SRRK)
Fate Therapeutics (FATE)
Regenxbio Inc equity us cm (RGNX)
Deciphera Pharmaceuticals (DCPH)
Kymera Therapeutics (KYMR)
Adc Therapeutics Sa SHS (ADCT)
Stoke Therapeutics (STOK)
Augmedix (AUGX)
Nurix Therapeutics (NRIX)
Biohaven (BHVN)
Beam Therapeutics (BEAM)
Zymeworks Del (ZYME)

View all positions for Redmile Group

Top funds holding D Fluidigm Corp Del

Casdin Capital
Viking Global Investors
Millennium Management
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Indaba Capital Management
BlackRock
Balyasny Asset Management
Neuberger Berman Group
Barclays
Goldman Sachs Group
PRIMECAP Management Company

View all funds holding D Fluidigm Corp Del